IP Library Granted Patent US 10,023,912
Granted Patent B2
US 10,023,912 · App. 14/960,000 · Granted Jul 17, 2018

In situ hybridization method and buffer

Inventors: Boye Schnack Nielsen (Copenhagen, DK); Stine Jørgensen (Copenhagen, DK); Jan Skouv (Espergaerde, DK); Adam Baker (Vedbaek, DK); Søren Møller (Holte, DK)
Assignee: EXIQON A/S
C12Q1/6876C12Q1/6832C12Q2600/178
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,023,912
App. No.
14/960,000
Granted
Jul 17, 2018
Kind
B2
Abstract

An improved method of in situ hybridization which relies on an improved formulation of the in situ hybridization buffer is described. In at least some formulations the buffer are non-toxic. The combination of Locked Nucleic Acid (LNA) comprising ISH probes and the improved ISH buffer are useful for detection of small non-coding RNA as well as in the manufacturing of ISH kits directed to the detection of such small non-coding RNA. Further disclosed is a method of semi-quantitative ISH and demonstration of the semi-quantitative ISHs diagnostic potential.

Claims (26)

1. A formamide-free, detergent-free hybridization buffer for detecting small non-coding RNAs in formalin-fixed and paraffin-embedded (FFPE) tissue sections with LNA-probes by in situ hybridization, the buffer comprising:

a hybrid stabilizing agent comprising salts of mono-valent cations, salts of di-valent cations, or salts of mono-valent cations and di-valent cations;

0. 5 to 5 M of a chaotropic component of urea, salts of guanidinium, salts of guanidine, or a mixture of two or more selected from the group consisting of urea, salts of guanidinium, and salts of guanidine;

Denhardt's Solution; and

a carrier RNA.

2. The hybridization buffer according to claim 1 , wherein the chaotropic component is urea, guanidine hydrochloride, or a mixture of urea and guanidine hydrochloride.

3. The hybridization buffer according to claim 1 , wherein the chaotropic component is urea.

4. The hybridization buffer according to claim 3 , wherein the buffer further comprises:

SSC;

2M urea;

Denhardt's Solution; and

0.25 mg/mL yeast t-RNA.

5. A kit for detecting at least one small non-coding RNAs in formalin-fixed and paraffin-embedded (FFPE) tissue by in situ hybridization, said kit comprising the formamide-free, hybridization buffer of claim 3 and least one LNA-probe optimized for specific detection of said one small non-coding RNA.

6. The kit according to claim 5 wherein the small non-coding RNA is a microRNA.

7. The kit according to claim 5 wherein the LNA-probe is labeled at both its 3′ end and the 5′-end with digoxigenin.

8. The kit according to claim 6 , wherein the LNA-probe is labeled at both its 3′ end and the 5′-end with digoxigenin.

9. The hybridization buffer according to claim 2 , wherein the chaotropic component is urea.

10. The hybridization buffer according to claim 9 , wherein the buffer further comprises:

a hybrid stabilizing agent comprising salts of mono-valent cations, salts of di-valent cations, or salts of mono-valent cations and di-valent cations;

urea;

Denhardt's Solution; and

a carrier RNA.

11. A kit for detecting at least one small non-coding RNA in formalin-fixed and paraffin-embedded (FFPE) tissue by in situ hybridization, said kit comprise the formamide-free, hybridization buffer of claim 10 and least one LNA-probe optimized for specific detection of said one small non-coding RNA.

12. The kit according to claim 11 , wherein the small non-coding RNA is a microRNA.

13. The kit according to claim 11 , wherein the LNA-probe is labeled at both its 3′ end and the 5′-end with digoxigenin.

14. The kit according to claim 12 , wherein the LNA-probe is labeled at both its 3′ end and the 5′-end with digoxigenin.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2019
From: EXIQON A/S
To: QIAGEN GMBH
Reel/Frame 048341/0295 →
Continuity (3)
Continuation 13695427
Provisional Application 61343596 · Apr 30, 2010
Related Publication 20160160278A1 · Jun 9, 2016